Comments
Loading...

TG Therapeutics

TGTXNASDAQ
Logo brought to you by Benzinga Data
$32.25
0.050.16%
Pre-Market: 4:40 AM EDT
Consensus Rating1
Buy
Highest Price Target1
$55.00
Lowest Price Target1
$5.00
Consensus Price Target1
$30.40

TG Therapeutics (NASDAQ:TGTX) Stock, Analyst Ratings, Price Targets, Forecasts

TG Therapeutics Inc has a consensus price target of $30.4 based on the ratings of 11 analysts. The high is $55 issued by HC Wainwright & Co. on November 5, 2024. The low is $5 issued by Goldman Sachs on April 19, 2022. The 3 most-recent analyst ratings were released by JP Morgan, HC Wainwright & Co., and Goldman Sachs on November 25, 2024, November 5, 2024, and November 5, 2024, respectively. With an average price target of $40 between JP Morgan, HC Wainwright & Co., and Goldman Sachs, there's an implied 24.03% upside for TG Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
2
1
Aug
1
Sep
1
Oct
2
1
Nov
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.5
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

JP Morgan
HC Wainwright & Co.
Goldman Sachs
TD Cowen
B. Riley Securities

1calculated from analyst ratings

Analyst Ratings for TG Therapeutics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for TG Therapeutics (TGTX) stock?

A

The latest price target for TG Therapeutics (NASDAQ:TGTX) was reported by JP Morgan on November 25, 2024. The analyst firm set a price target for $43.00 expecting TGTX to rise to within 12 months (a possible 33.33% upside). 18 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for TG Therapeutics (TGTX)?

A

The latest analyst rating for TG Therapeutics (NASDAQ:TGTX) was provided by JP Morgan, and TG Therapeutics maintained their overweight rating.

Q

When was the last upgrade for TG Therapeutics (TGTX)?

A

The last upgrade for TG Therapeutics Inc happened on August 2, 2023 when Goldman Sachs raised their price target to $12. Goldman Sachs previously had a sell for TG Therapeutics Inc.

Q

When was the last downgrade for TG Therapeutics (TGTX)?

A

There is no last downgrade for TG Therapeutics.

Q

When is the next analyst rating going to be posted or updated for TG Therapeutics (TGTX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of TG Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for TG Therapeutics was filed on November 25, 2024 so you should expect the next rating to be made available sometime around November 25, 2025.

Q

Is the Analyst Rating TG Therapeutics (TGTX) correct?

A

While ratings are subjective and will change, the latest TG Therapeutics (TGTX) rating was a maintained with a price target of $30.00 to $43.00. The current price TG Therapeutics (TGTX) is trading at is $32.25, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch